HOME-PHIL RIVERS TECHNOLOGY Co.,Ltd

A digital simulation platform for mining intrinsic mechanisms
of actions (MOAs) of drugs

Establishing digital models reflecting etiologies and pathologies of human diseases as well as pharmacology and MOAs of drugs

Systematically delivering novel targets
and new MOAs of drugs

Boosting new drug pipelines for unmet clinical needs

Virtual clinical trials

※    Accurate assessment of drug targets
※    Precise simulation of drug efficacy
※    Precisely pinpoint applicable indications
※    Accurately predicting responders to therapies

11

2023-01

Senior immunologist Dr. Jianfei Yang joined PHIL RIVERS Technology as Chief Scientific Officer and debuted JPM Week

Recently, Phil Rivers Technology (Beijing) Ltd. announced that Dr. Jianfei Yang ···
27

2022-09

CAPR2022 | Phil Rivers Invited to Share New Practice of "AI+ Disease"

In recent years, the topic of AI drug development has received extensive attenti···
20

2022-09

2022 Hefei Scenario Innovation Conference | Phil Rivers annual best scenario Award

On September 16, 2022, the 1st China (Hefei) Scenario Innovation Conference spon···
10

2022-09

NIB | Phil Rivers won the award for Biomedical "Rising Star"

On September 7, 2022, the award ceremony of " Rising Star" of biomedic···
29

2022-08

CSDR and Relevant Units to Investigate "Computational Medicine"

CSDR and Relevant Units to Investigate "Computational Medicine"
29

2022-08

2022 Suzhou Dialogue | Phil Rivers Zhao Yu was invited to give an opening speech

On August 26, 2022, the special session "Production Quality Management in t···
22

2022-08

2022 dTrial | Phil Rivers's virtual clinical trials application cases

From August 19 to 20, 2022, DIA China Digital Clinical Trial Innovation Forum (d···
15

2022-08

2nd AI Drug R&D Conference | Phil Rivers’s Digital Testing Ground for Drug Development Makes a Wonderful Appearance

On August 10-11, 2022, the "Second AI Drug R & D Conference and AI Inte···


	support@philrivers.com

	※ Room 314, Office of CHINA SCIENCE DAILY, B3 South No.1 Road, Zhongguancun, Haidian District, Beijing, China
	※ Industrialization Complex Building,Rm B603-B604,Shenzhen Virtual University,Shenzhen,China


	support@philrivers.com

	Room 314, Office of CHINA SCIENCE DAILY, B3 South No.1 Road, Zhongguancun, Haidian District, Beijing, China
	Industrialization Complex Building,Rm B603-B604,Shenzhen Virtual University,Shenzhen,China

A digital simulation platform for mining intrinsic mechanisms of actions (MOAs) of drugs

Systematically delivering novel targets and new MOAs of drugs

Virtual clinical trials

NEWS

11

2023-01

Senior immunologist Dr. Jianfei Yang joined PHIL RIVERS Technology as Chief Scientific Officer and debuted JPM Week

27

2022-09

CAPR2022 | Phil Rivers Invited to Share New Practice of "AI+ Disease"

20

2022-09

2022 Hefei Scenario Innovation Conference | Phil Rivers annual best scenario Award

10

2022-09

NIB | Phil Rivers won the award for Biomedical "Rising Star"

29

2022-08

CSDR and Relevant Units to Investigate "Computational Medicine"

29

2022-08

2022 Suzhou Dialogue | Phil Rivers Zhao Yu was invited to give an opening speech

22

2022-08

2022 dTrial | Phil Rivers's virtual clinical trials application cases

15

2022-08

2nd AI Drug R&D Conference | Phil Rivers’s Digital Testing Ground for Drug Development Makes a Wonderful Appearance

A digital simulation platform for mining intrinsic mechanisms
of actions (MOAs) of drugs

Systematically delivering novel targets
and new MOAs of drugs